Pharmaceutical Specifications and Chemical Profile
Oxanabol is a pharmaceutical-grade oral anabolic steroid manufactured by Alpha Pharma containing oxandrolone as the active compound. This synthetic derivative of dihydrotestosterone features modifications at the 2-oxa and 17α-methyl positions, creating a unique molecular structure optimised for oral bioavailability in research applications. The compound exhibits tissue-selective anabolic properties in preclinical models, making it valuable for studies investigating steroid receptor modulation and anabolic pathway mechanisms. Research laboratories at Stroid UK Shop utilise this pharmaceutical preparation for controlled experimental protocols.
Laboratory Research Applications
Scientific investigations with Oxanabol focus on its distinctive pharmacological profile compared to other anabolic steroids. Research models demonstrate reduced androgenic activity relative to testosterone while maintaining anabolic effects in muscle tissue studies. The compound’s structural modifications result in resistance to 5α-reductase metabolism, providing consistent activity levels in experimental systems. Comparative studies within oral steroids research categories examine its unique properties against other anabolic compounds. Laboratory protocols investigate hepatic metabolism pathways, protein synthesis modulation, and nitrogen retention mechanisms. Researchers also study its interactions with androgen receptors in various tissue types, comparing responses to those observed with SARMs compounds and peptide modulators in controlled experimental conditions.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 17β-hydroxy-17α-methyl-2-oxa-5α-androstan-3-one |
| CAS Registry Number | 53-39-4 |
| Molecular Formula | C₁₉H₃₀O₃ |
| Molecular Weight | 306.44 g/mol |
| Manufacturer | Alpha Pharma |
| Presentation | Oral tablets |
| Storage Requirements | Room temperature, dry conditions |
| Solubility | Lipophilic compound |
Research Compliance and Laboratory Use
This pharmaceutical preparation is supplied exclusively for in-vitro laboratory research and analytical applications. Research facilities must maintain appropriate licensing for handling scheduled substances and implement proper storage protocols according to regulatory requirements. The compound should be handled only by qualified researchers using appropriate safety equipment and following institutional guidelines for anabolic steroid research. All experimental protocols must comply with applicable regulations governing research use of controlled substances. This product is not intended for human consumption, therapeutic use, or any application outside legitimate scientific research environments.
